The deeper threat to the biopharmaceutical industry may come not from macro-level disruption, but from structural pressures ...

How AI and other digital tools are progressing across the bio/pharmaceutical industry is on top of mind. Key perspectives on ...

Merck KGaA has agreed to acquire Silence Therapeutics, a Cambridge, UK-based clinical-stage bio/pharmaceutical company developing short interfering RNA (siRNA) medicines, for $1.3 billion, ...

Sanofi has broken ground on a new insulin manufacturing facility in Frankfurt, Germany. The new facility will be built on a 36,000-square-meter footprint at the Sanofi BioCampus in Frankfurt.

A recent KPMG study of more than 1,300 CEOs at large companies globally, including 400 US companies, say supply-chain cost ...

The Board of Directors of CSL, a Melbourne, Australia-based bio/pharmaceutical company, has appointed Deborah Waterhouse, currently Chief Executive Officer (CEO) of ViiV Healthcare, a joint venture ...

What are key trends for injectable drugs and the related market impact? From switches from IV-administered to subcutaneous drug delivery and increased interest for home and self administration, DCAT ...

Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view all ...

Earlier this month (July 2025), the European Commission presented an Action Plan for the Chemicals Industry to strengthen the competitiveness and modernization of the EU chemicals sector. The Action ...